Sort
39,280 grants matching “leukemia”
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
$648,482Kelly E Dunn · Johns Hopkins University · R01 · FY2016 · DA
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies
$648,472Iris Z Jaffe · Tufts Medical Center · R01 · FY2024 · HL
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu
$648,389Harlan S. Robins · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu
$648,389Harlan S. Robins · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu
$648,389Harlan S. Robins · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Targeting Alloreactivity for Leukemia Eradication
$648,309Stanley R Riddell · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
Define the oncogenic role of METTL3 in the pathogenesis of chronic lymphocytic leukemia
$648,241Lili Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Impact of mutational order on molecular mechanisms of oncogenesis
$648,012Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Biological determinants of colorectal cancer outcomes in Latinos of diverseýancestral origins
$647,843Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
Targeting the menin-MLL1 complex for new therapeutics
$647,740Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
ALL immunobiology and the bone marrow niche
$647,674Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Improved Chimeric Antigen Receptor Therapies B-cell Malignancies
$647,651James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
REGULATION OF HEMATOPOIETIC PROGENITORS BY DE NOVO DNA METHYLATION
$647,536Margaret Goodell · Baylor College Of Medicine · R01 · FY2023 · DK
Targeting minimal residual disease in AML by using single-cell morphological and biophysical analysis with deep learning
$647,458Scott R Manalis · Massachusetts Institute Of Technology · U01 · FY2024 · CA
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
$647,349Stefanie Sarantopoulos · Duke University · R01 · FY2015 · HL
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
$647,099Christopher J Kemp · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Small-molecule MDM2 degraders
$647,004Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Small-molecule degraders of STAT5
$646,994Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Gene Therapy for Canine X-linked SCID
$646,933Peter J Felsburg · University Of Pennsylvania · R01 · FY2009 · AI
Targeting the menin-MLL1 complex for new therapeutics
$646,858Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Small-molecule degraders of STAT5
$646,849Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Targeting the menin-MLL1 complex for new therapeutics
$646,774Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Biology of R-Spondin-Induced Sensitization to Asparaginase in Colorectal Cancer
$646,719Alejandro Gutierrez · St. Jude Children'S Research Hospital · R01 · FY2025 · CA
The Role of HIF1A-DNMT3A axis in AML1/ETO-Driven Acute Myelogenous Leukemia
$646,651Shujun Liu · University Of Minnesota · R01 · FY2022 · CA
Development of P2Y Receptor Ligands
$646,531Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK